期刊文献+

不可分型流感嗜血杆菌蛋白D研究进展 被引量:3

Advances in the research of protein D of nontypeable Haemophilus influenzae
原文传递
导出
摘要 流感嗜血杆菌(Haemophilus influenzae,Hi)蛋白D(Protein D,PD)是高度保守的表面脂蛋白,相对分子质量42 000,存在于所有的可分型Hi和不可分型Hi(nontypeable Haemophilus influenzae,NTHi)中,是一种具有甘油磷酸二酯酶活性的细菌毒力因子,能导致宿主上皮细胞释放磷酸胆碱,在Hi引起呼吸道感染过程中起重要作用.以NTHi PD作为载体蛋白的肺炎链球菌多糖结合疫苗,不但能预防肺炎链球菌性耳炎,而且对NTHi引起的急性中耳炎也具有预防作用.PD是迄今为止第一种能在人类机体中诱导保护性应答的NTHi抗原,也是最具潜力的多糖结合疫苗候选载体蛋白. Protein D (PD) is a highly conserved surface lipoprotein(M, 42 000) found in all Hae mophilus influenzae (Hi), including nontypeable Haemophilus influenzae (NTHi).PD is a virulence factor with glycerophosphodiesterase activity, which can lead to the release of phosphorylcholine from host epithelial cells, and plays an important role in the pathogenesis of respiratory tract infection caused by Hi.Pneumococcal polysaccharide conjugate vaccine using NTHi PD as a carrier protein can protect against acute otitis media caused by both pneumococci and NTHi.PD is not only a potential carrier protein candidate for polysaccharide conjugate vaccines but also the first NTHi antigen which can induce protective response in human.
出处 《国际生物制品学杂志》 CAS 2010年第4期205-208,共4页 International Journal of Biologicals
关键词 嗜血菌 流感 载体蛋白质类 抗原 蛋白D Haemophilus influenzae Carrier proteins Antigens Protein D
  • 相关文献

参考文献21

  • 1Lacross NC,Mans CF,Patel M,et al.High genetic diversity of nontypeable Haemophilia influenzae isolates from two children attending a day care center[J].J Clin Microbiol,2008,46(11):3817-3821.
  • 2Murphy TF,Kirkham C,Lease AJ.Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilia influenzae[J].Infect Inunun,2006,74(9):5169-5176.
  • 3Ptymula R,Peelers P,Chrobok V,et al.Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae:a randomised double-blind efficacy study[J].Lancet,2006,367(9512):740-748.
  • 4Sasaki K,Munson RS Jr.Protein D of Haemophilus influenzae is not a universal immunoglobulin D-binding protein[J].Infect Immun,1993,61(7):3026-3031.
  • 5Duim B,Ruiter P,Bowler LD,et al.Sequence variation in the hpd gene of nonencapsulated Haemophilus influenzae isolated from patients with chronic bronchitis[J].Gene,1997,191(1):57-60.
  • 6Toropainen M,Raitolehto A,Henckaerts I,et al.Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D[J].Infect Immun,2008,76(10):4546-4553.
  • 7Fan X,Goldfine H,Lysenko E,et al.The transfer of choline from the host to the bacterial cell surface requires glpQ in Haemophilus influenzae[J].Mol Microbiol,2001,41 (5):1029-1036.
  • 8Erwin AL,Smith AL.Nontypeable Haemophilus influenzae:understanding virulence and commensal behavior[J].Trends Microbiol,2007,15(8):355-362.
  • 9Ahrén IL,Janson H,Forsgren A,et al.Protein D expression promotes the adherence and internalization of non-typeable Haemophilus influenzae into human monocytic cells[J].Microb Pathog,2001,31(3):151-158.
  • 10Swords WE,Buscher BA,Ver Steeg li K,et al.Non-typeable Haemophilia influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor[J].Mol Microbiol,2000,37(1):13-27.

同被引文献58

  • 1刘方蕾,吴兵,杜琳,杨淼,王志军,杨福军,罗广.A群奈瑟氏脑膜炎球菌荚膜多糖-破伤风类毒素结合疫苗的制备及其免疫原性研究[J].微生物学免疫学进展,2005,33(2):14-20. 被引量:8
  • 2吴兵,刘方蕾,崔萱林,杜琳,杨淼,王志军,冯君平.C群奈瑟氏脑膜炎球菌荚膜多糖-TT结合疫苗的制备及其在小鼠体内免疫原性的研究[J].微生物学免疫学进展,2005,33(3):12-18. 被引量:5
  • 3张萍,王欣茹,侯亚莉,张新庄,杜琳,谢贵林.14型肺炎球菌荚膜多糖-破伤风类毒素结合疫苗的研制[J].微生物学免疫学进展,2007,35(1):1-4. 被引量:6
  • 4Dick WE Jr, Beurret M. Glycoconjugates of bacterial carbohydrate antigens. A survey and consideration of design andpreparation factors [ J]. Contrib Microbiol Immunol, 1989, 10: 48-114.
  • 5Lee CR, Frasch CE. Polysaccharide-protein conjugate vaccines: US, W0/2005/014037 [P].
  • 6Pawlowskia A, Kallenius G, Svenson SB. Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies [J]. Vaccine, 2000, 18 ( 18 ) : 1873-1885.
  • 7Boker M, Dull PM, Rappuoti R, et al. Chemistry of a new investigationat quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages [J]. Vaccine, 2009, 27(41 ) :5574- 5580.
  • 8Snape MD, Perrett KP, Ford KJ, et al. hnmunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial [ J ]. JAMA, 2008, 299 ( 2 ) : 173-184.
  • 9Jackson LA, Jacobson RM, Reisinger KS, et al. A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents [J]. Pediatr Infect Dis J, 2009, 28(2) :86-91.
  • 10Robbins JB , Schneerson R , Szu SC. Perspective hypothesis : serum IgG antibody is sufficient to confer protection against infections diseases by inactivating the inoculums [ J ]. J Infect Dis, 1995, 171 (6) : 1387-1398.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部